Suflave is expected to be available in early August 2023. The Food and Drug Administration (FDA) has approved Suflave™ (polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, ...
The FDA granted Check-Cap’s C-Scan an investigational device exemption March 15 that will allow the test to launch a clinical study in the U.S. The C-Scan test is a capsule-based screening technology ...
VANCOUVER, British Columbia, July 22, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTCQB: BVAXF) ("BioVaxys"), is pleased to announce today that the US Food and Drug ...
BRAINTREE, Mass., June 22, 2023 /PRNewswire/ -- Sebela Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) granted approval of SUFLAVE ™ (polyethylene glycol, sodium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback